Patents by Inventor Pierre LaCasse

Pierre LaCasse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130064845
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 14, 2013
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • Patent number: 7826228
    Abstract: Disclosed is a piston reset apparatus for a multichip module that includes a base with multiple projections and two unit associating pegs extending from opposite ends of the base, a hat disposed upwardly of the base and including multiple adjustable pistons vertically adjustable within the hat, each of the plurality of adjustable pistons being disposed in alignment with one of the multiple projections, a mass equivalent plate disposed upwardly of the hat and being configured to hold a spring loaded sleeve, the spring loaded sleeve including a plurality of springs, each of the springs being aligned with and configured to apply pressure upon one of the multiple pistons, a spring loaded clamp disposed upwardly of the plate and including a spring loaded portion and a retaining portion, the retaining portion defining two cavities configured to fixedly associate with an associating groove defined by each of the unit associating pegs.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: November 2, 2010
    Assignee: International Business Machines Corporation
    Inventors: Gerald P. Audet, Sylvain Dussault, Pierre LaCasse, Jean-Luc Landreville
  • Publication number: 20080264606
    Abstract: Disclosed is a piston reset apparatus for a multichip module that includes a base with multiple projections and two unit associating pegs extending from opposite ends of the base, a hat disposed upwardly of the base and including multiple adjustable pistons vertically adjustable within the hat, each of the plurality of adjustable pistons being disposed in alignment with one of the multiple projections, a mass equivalent plate disposed upwardly of the hat and being configured to hold a spring loaded sleeve, the spring loaded sleeve including a plurality of springs, each of the springs being aligned with and configured to apply pressure upon one of the multiple pistons, a spring loaded clamp disposed upwardly of the plate and including a spring loaded portion and a retaining portion, the retaining portion defining two cavities configured to fixedly associate with an associating groove defined by each of the unit associating pegs.
    Type: Application
    Filed: June 23, 2008
    Publication date: October 30, 2008
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Gerald P. Audet, Sylvain Dussault, Pierre LaCasse, Jean-Luc Landreville
  • Publication number: 20080207491
    Abstract: The present invention relates to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increase susceptibility and can reverse resistance of microorganism to antibiotics.
    Type: Application
    Filed: October 31, 2007
    Publication date: August 28, 2008
    Inventors: Moussa S. Diarra, Pierre Lacasse, Denis Petitclerc
  • Patent number: 7405940
    Abstract: Disclosed is a piston reset apparatus for a multichip module that includes a base with multiple projections and two unit associating pegs extending from opposite ends of the base, a hat disposed upwardly of the base and including multiple adjustable pistons vertically adjustable within the hat, each of the plurality of adjustable pistons being disposed in alignment with one of the multiple projections, a mass equivalent plate disposed upwardly of the hat and being configured to hold a spring loaded sleeve, the spring loaded sleeve including a plurality of springs, each of the springs being aligned with and configured to apply pressure upon one of the multiple pistons, a spring loaded clamp disposed upwardly of the plate and including a spring loaded portion and a retaining portion, the retaining portion defining two cavities configured to fixedly associate with an associating groove defined by each of the unit associating pegs.
    Type: Grant
    Filed: April 25, 2007
    Date of Patent: July 29, 2008
    Assignee: International Business Machines Corporation
    Inventors: Gerald P. Audet, Sylvain Dussault, Pierre LaCasse, Jean-Luc Landreville
  • Patent number: 7277744
    Abstract: The present invention provides a method for the detection of inflammation in animals using infrared thermography. The invention also provides a method for the detection of diseases or disorders that induce inflammation using infrared thermography. The present invention further provides a method for the detection of infections in animals using infrared thermography.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: October 2, 2007
    Inventors: Allan L. Schaefer, Shannon L. Scott, Pierre LaCasse, Alan K. W. Tong
  • Publication number: 20060142183
    Abstract: The present invention related to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increased susceptibility and can reverse resistance of microorganism to antibiotics.
    Type: Application
    Filed: November 23, 2005
    Publication date: June 29, 2006
    Inventors: Moussa Diarra, Pierre LaCasse, Denis Petitclerc
  • Publication number: 20040019269
    Abstract: The present invention provides a method for the detection of inflammation in animals using infrared thermography. The invention also provides a method for the detection of diseases or disorders that induce inflammation using infrared thermography. The present invention further provides a method for the detection of infections in animals using infrared thermography.
    Type: Application
    Filed: May 27, 2003
    Publication date: January 29, 2004
    Inventors: Allan L. Schaefer, Shannon L. Scott, Pierre LaCasse, Alan K.W. Tong
  • Publication number: 20030134779
    Abstract: The present invention relates to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increase susceptibility and can reverse resistance of microorganism to antibiotics.
    Type: Application
    Filed: September 23, 2002
    Publication date: July 17, 2003
    Inventors: Moussa S. Diarra, Pierre Lacasse, Denis Petitclerc
  • Publication number: 20030087864
    Abstract: The present invention relates to the use of a plasmid encoding Staphylococcus aureus polypeptides and its use in the preparation of compositions and vaccines. More specifically, the present invention is concerned with compositions, DNA vaccines and methods for providing an immune response and/or a protective immunity into mammals against a Staphylococcus aureus associated disease, such as mastitis. The plasmid used in the composition or DNA vaccine comprises at least one nucleotide coding sequence of a Staphylococcus aureus polypeptide, such as the Clumping factor A (ClfA), the fibronectin-binding protein A, the sortase-A or the pre-pheromone (ArgD).
    Type: Application
    Filed: July 9, 2002
    Publication date: May 8, 2003
    Inventors: Brian Talbot, Eric Brouillette, Pierre Lacasse